Literature DB >> 22942847

A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture.

Neal C Chen, Ramesh C Srinivasan, Melissa J Shauver, Kevin C Chung.   

Abstract

BACKGROUND: Needle aponeurotomy and collagenase injection are alternative treatments of Dupuytren's contracture to open partial fasciectomy; however, reported data are difficult to interpret without a formal systematic review.
METHODS: A Medline, EMBASE, and Cochrane database search was performed, and 277 articles were identified. Articles were stratified by level of evidence, and those of the highest level for each technique were included. Evidence available for needle aponeurotomy was of low quality so only cohorts larger than 100 patients were included.
RESULTS: The sample size of patients for open partial fasciectomy ranged from 37-261. The recurrence rate ranged from 12-39%, with mean follow-up time of 1.5-7.3 years. The complication rate ranged from 14-67%. Complications included nerve division (2-5%), infection (4-12%), neurapraxia (0.4-52%), and regional pain syndrome (2-13%). For needle aponeurotomy the sample size ranged from 117-211. The recurrence rate ranged from 50-58%, with mean follow-up time of 3-5 years. With regard to collagenase injection, the sample size ranged from 13-204. The recurrence rate ranged from 10-31%, with mean follow-up time of 120 days to 4 years. For the two latter procedures, adverse effects consisted primarily of skin tears (9-25%). Kruskal-Wallis testing demonstrated that the recurrence rate was significantly higher for needle aponeurotomy than for open partial fasciectomy (p = 0.001), and the recurrence rate was significantly higher for open partial fasciectomy than for collagenase injection (p = 0.001).
CONCLUSIONS: The recurrence rates and types of complications differ between open partial fasciectomy and needle aponeurotomy or collagenase injection. Long-term outcomes have not been well reported.

Entities:  

Keywords:  Complications; Dupuytren’s contracture; Evidence; Outcomes; Systematic review

Year:  2011        PMID: 22942847      PMCID: PMC3153627          DOI: 10.1007/s11552-011-9326-8

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  18 in total

1.  Results following surgery for recurrent Dupuytren's disease.

Authors:  T F Roush; P J Stern
Journal:  J Hand Surg Am       Date:  2000-03       Impact factor: 2.230

Review 2.  The outcome of surgical treatments for primary Dupuytren's disease--a systematic review.

Authors:  G W Becker; T R C Davis
Journal:  J Hand Surg Eur Vol       Date:  2010-07-09

3.  Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients.

Authors:  J Henk Coert; Juan P Barret Nérin; Marcel F Meek
Journal:  Ann Plast Surg       Date:  2006-07       Impact factor: 1.539

4.  Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients.

Authors:  T Balaguer; S David; T Ihrai; N Cardot; G Daideri; E Lebreton
Journal:  J Hand Surg Eur Vol       Date:  2009-08

5.  The complications of Dupuytren's contracture surgery.

Authors:  Neil W Bulstrode; Barbara Jemec; Paul J Smith
Journal:  J Hand Surg Am       Date:  2005-09       Impact factor: 2.230

6.  Prediction of recurrence in the treatment of Dupuytren's disease: evaluation of a histologic classification.

Authors:  J J Rombouts; H Noël; Y Legrain; E Munting
Journal:  J Hand Surg Am       Date:  1989-07       Impact factor: 2.230

7.  Recurrence after surgery for Dupuytren's disease: a randomized trial of two skin incisions.

Authors:  N D Citron; V Nunez
Journal:  J Hand Surg Br       Date:  2005-09-06

8.  [Non-surgical treatment of Dupuytren disease using needle fasciotomy].

Authors:  F J Badois; J L Lermusiaux; C Massé; D Kuntz
Journal:  Rev Rhum Ed Fr       Date:  1993-11-30

9.  A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study.

Authors:  Annet L van Rijssen; Feike S J Gerbrandy; Hein Ter Linden; Helen Klip; Paul M N Werker
Journal:  J Hand Surg Am       Date:  2006 May-Jun       Impact factor: 2.230

10.  Does a 'firebreak' full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture?: a prospective, randomised trial.

Authors:  A S Ullah; J J Dias; B Bhowal
Journal:  J Bone Joint Surg Br       Date:  2009-03
View more
  25 in total

1.  The "Bowstring Arch Bridge" Analogy to Guide Sequential Portal Placement during Needle Aponeurotomy in the Treatment of Dupuytren Contracture.

Authors:  Roshin Thomas
Journal:  J Hand Microsurg       Date:  2016-09-23

2.  SNPs previously associated with Dupuytren's disease replicated in a North American cohort.

Authors:  Eric R Anderson; Zhan Ye; Michael D Caldwell; James K Burmester
Journal:  Clin Med Res       Date:  2014-02-26

Review 3.  Dupuytren's disease: current state of the art.

Authors:  Mark Henry
Journal:  Hand (N Y)       Date:  2014-03

4.  Phalangeal fracture leading to digital amputation, sustained during manipulation for Dupuytren's disease as part of clostridial collagenase treatment.

Authors:  K Richards; C Sethu; E Tiernan
Journal:  Ann R Coll Surg Engl       Date:  2019-03-11       Impact factor: 1.891

5.  [Treatment of Dupuytren's disease with collagenase Clostridium histolyticum].

Authors:  M Keller; R Arora; G Schmiedle; T Kastenberger
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

6.  Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren contracture: report of 40 cases.

Authors:  F Alberton; M Corain; A Garofano; L Pangallo; A Valore; V Zanella; R Adani
Journal:  Musculoskelet Surg       Date:  2013-11-20

7.  Effect of nanoparticle-mediated delivery of SFRP4 siRNA for treating Dupuytren disease.

Authors:  Rujue Jin; Weigang Zhu; Jiajun Xu; Jianhui Gu; Aidong Deng
Journal:  Gene Ther       Date:  2022-03-28       Impact factor: 5.250

8.  Feasibility of aponeurectomy in combination with perioperative 192Ir high dose rate brachytherapy for Dupuytren's disease.

Authors:  I Frank Ciernik; Philipp Goldschmidt; Markus Wösle; Jochen Winter
Journal:  Strahlenther Onkol       Date:  2021-09-07       Impact factor: 3.621

9.  Nonsurgical treatment of Dupuytren's contracture: 1-year US post-marketing safety data for collagenase clostridium histolyticum.

Authors:  C A Peimer; C A McGoldrick; G J Fiore
Journal:  Hand (N Y)       Date:  2012-06

10.  Psychometric properties of health-related quality of life instruments in patients undergoing palmar fasciectomy for dupuytren's disease: a prospective study.

Authors:  Achilleas Thoma; Manraj Nirmal Kaur; Teegan Aili Ignacy; Carolyn Levis; Stuart Martin; Eric Duku; Ted Haines
Journal:  Hand (N Y)       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.